Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Enhertu approved in the EU for patients with previously treated HER2-positive advanced gastric cancer

Tuesday, December 20, 2022

AstraZeneca and Daiichi Sankyos Enhertu trastuzumab deruxtecan has been approved in the European Union EU as monotherapy for the treatment of adult patients with advanced HERpositive gastric or gastroesophageal junction GEJ adenocarcinoma who have re...

Psyence and Filament Health Announce Worldwide Licensing Agreement of Psilocybin Capsule for Palliative Care

Friday, December 16, 2022

Filament Health Corp a clinicalstage natural psychedelic drug development company and Psyence Group Inc a life science biotechnology company pioneering the use of natural psilocybin in mental health and wellbeing today announced the conclusion of a r...

Fresenius Kabi Targets Treatment of Certain Seizures with Launch of Generic Lacosamide Injection, USP

Friday, December 16, 2022

Fresenius Kabi announced today the immediate availability in the US of Lacosamide Injection USP a generic equivalent to VIMPAT Fresenius Kabi Lacosamide Injection USP is an approved treatment option for partialonset seizures in patients years of age...

Exicure, Inc. Announces Termination of AbbVie and Ipsen Collaboration Agreements

Thursday, December 15, 2022

Exicure Inc an earlystage biotechnology company historically focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets today announced the termination of its collaboration agreements with AbbVie Inc AbbVie and...

Ono Enters into a Multi Target R&D Collaboration Agreement with PrecisionLife

Thursday, December 15, 2022

Ono Pharmaceutical Co Ltd today announced that it has entered into a multi target RD collaboration agreement with PrecisionLife Limited a global techbio company generating the deepest insights into disease biology to create novel precision medicines...

UCB and Praxis Precision Medicines Announce Epilepsy Research Collaboration

Wednesday, December 14, 2022

UCB a global biopharmaceutical company and Praxis Precision Medicines Inc a clinicalstage biopharmaceutical company today announced a strategic collaboration based upon Praxis PRAX program for the discovery of small molecule therapeutics as potential...

Biosion Announces Research Collaboration with ImmunoGen to Create Novel Antibody-Drug Conjugates

Wednesday, December 14, 2022

Biosion USA Inc a global RD biotechnology company today announced an exploratory research collaboration to create antibodydrug conjugates ADCs for the treatment of cancer with ImmunoGen Inc a leader in developing next generation ADCs In the joint res...

Merck Begins Tender Offer to Acquire Imago BioSciences, Inc.

Tuesday, December 13, 2022

Merck known as MSD outside of the United States and Canada is commencing today through a subsidiary a cash tender offer to purchase all outstanding shares of common stock of Imago BioSciences Inc Nasdaq IMGO On Nov Merck announced that it had enter...

Pasithea Therapeutics Announces Comprehensive Settlement Agreement with the Camac Group

Tuesday, December 13, 2022

Pasithea Therapeutics Corp a biotechnology company focused on the discovery research and development of innovative treatments for central nervous system CNS disorders today announced that it has reached a comprehensive Settlement and Cooperation Agre...

Efruxifermin Granted FDA Breakthrough Therapy Designation for NASH

Friday, December 09, 2022

Akero Therapeutics Inc a clinicalstage company developing transformational treatments for patients with serious metabolic disease marked by high unmet medical need today announced that efruxifermin EFX has received a Breakthrough Therapy Designation...